4 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2198761/here-s-why-you-should-retain-catalent-ctlt-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2198761
Dec 15, 2023 - Catalent's (CTLT) products and services portfolio and technology foundation raise optimism about the stock.
zc:8425012866255595287
0
https://www.zacks.com/stock/news/2221276/novo-nordisk-nvo-to-acquire-3-catalent-sites-for-11b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221276
Feb 05, 2024 - Novo Nordisk (NVO) will acquire Catalent's three manufacturing sites from Novo Holdings to expand its manufacturing capacity.
zc:-6141064885127696638
0
https://www.zacks.com/stock/news/2224065/catalent-ctlt-q2-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2224065
Feb 09, 2024 - Although the revenue and EPS for Catalent (CTLT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:5203772513347225770
0
https://www.zacks.com/stock/news/2206898/stock-market-news-for-jan-8-2024?cid=CS-ZC-FT-market_news-2206898
Jan 08, 2024 - Wall Street closed higher after a choppy session on Friday to finish the first week of 2024.
zc:-3875873834889803901
0